Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton’s tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)
2018 ◽
pp. molcanther.0478.2018
◽
2021 ◽
Keyword(s):
2020 ◽
Vol 34
(5)
◽
pp. 923-939
2020 ◽
Vol 20
◽
pp. S259-S260